TrialClinical pharmacology in drug development2018

Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers.

Temitope Adeloye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.